Home | GSK US
We all know Alyson Hannigan from the roles we love, but now she’s stepping into a new one: advocate and spokesperson for GSK’s Ask2BSure campaign. Teaming up with pediatrician Dr. …
Gepotidacin accepted for priority review by the US FDA for the …
Aug 11, 2025 · Gepotidacin, discovered by GSK scientists, is a bactericidal, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by a distinct binding site, …
Careers | GSK US
At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, …
Products - GSK US
Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more …
US FDA approves GSK’s SHINGRIX in a prefilled syringe …
Jul 17, 2025 · GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster …
Company | GSK US
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs.
Contact us - GSK
Disaster response - Contact our US Response Center online if you need help accessing your GSK medicines during a natural disaster. Patient Assistance Programs - We are committed to …
Press releases - GSK US
Jul 23, 2025 · GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/refractory multiple myeloma
GSK announces extension of US Food and Drug Administration …
Jul 23, 2025 · GSK is confident in the data supporting Blenrep combinations and looks forward to ongoing constructive conversations with the FDA as they continue their review.
GSK begins shipping influenza vaccine doses for the 2025-26 flu …
Jul 10, 2025 · GSK has begun shipping trivalent flu vaccine doses to US healthcare providers and pharmacies for the 2025–26 flu season.